Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Paclitaxel × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 98 Thoracic 10 Breast 8 Genitourinary 6 Gastrointestinal 6 Dermatologic 4 Sarcoma 3 Head & Neck 3 Lymphoid 2 Endocrine 2 Other solid neoplasm 1 Other hematologic neoplasm 1 NET 1 Classical hematology 1 CNS 1

Conditions

Carcinoma, Ovarian Epithelial 1 Anemia 1

Interventions

talazoparib 1 Therapeutics 1 SLC25A33 protein, human 1 Paclitaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00189371 2005-09-19

Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum

AGO Study Group

Phase 3 Terminated

Classical hematologyGynecologic

Carcinoma, Ovarian Epithelial, Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡